Literature DB >> 31093997

Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland.

Jong Jin Hyun1,2, J Bart Rose3, Adnan A Alseidi4, Thomas R Biehl4, Scott Helton4, David L Coy5, Richard A Kozarek2, Flavio G Rocha2,4.   

Abstract

BACKGROUND AND OBJECTIVES: Unlike pancreatic head tumors, little is known about the biological significance of radiographic vessel involvement with pancreatic body/tail adenocarcinoma. We hypothesized radiographic splenic vessel involvement may be an adverse prognostic factor.
METHODS: All distal pancreatectomies performed for resectable pancreatic adenocarcinoma between 2000 and 2016 were reviewed and clinicopatholgic data were collected, retrospectively. Preoperative computed tomography imaging was re-reviewed and splenic vessel involvement was graded as none, abutment, encasement, or occlusion.
RESULTS: Among a total of 71 patients, splenic artery or vein encasement/occlusion was present in 41% (29 of 71) of patients, each. There were no significant differences in tumor size or grade, margin positivity, and perineural or lymphovascular invasion. However, splenic artery encasement/occlusion (P = 0.001) and splenic vein encasement/occlusion (P = 0.038) both correlated with lymph node positivity. Splenic artery encasement was associated with a reduced median overall survival (20 vs 30 months, P = 0.033). Multivariate analysis also showed that splenic artery encasement was an independent risk factor of worse survival (hazard ratio, 2.246; 95% confidence interval, 1.118-4.513; P = 0.023).
CONCLUSION: Patients with cancer of the body or tail of the pancreas presenting with radiographic encasement of the splenic artery, but not the splenic vein, have a poorer prognosis and perhaps should be considered for neoadjuvant therapy before an attempt at curative resection.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  pancreatic adenocarcinoma; preoperative radiographic assessment; splenic vessel involvement

Mesh:

Year:  2019        PMID: 31093997     DOI: 10.1002/jso.25498

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Radiographic Splenic Artery Involvement Is a Poor Prognostic Factor in Upfront Surgery for Patients with Resectable Pancreatic Body and Tail Cancer.

Authors:  Manabu Kawai; Seiko Hirono; Ken-Ichi Okada; Motoki Miyazawa; Yuji Kitahata; Ryohei Kobayashi; Masaki Ueno; Shinya Hayami; Hiroki Yamaue
Journal:  Ann Surg Oncol       Date:  2020-07-23       Impact factor: 5.344

2.  Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.

Authors:  Linda C Chu; Zhen J Wang; Avinash Kambadakone; Elizabeth M Hecht; Jin He; Amol K Narang; Daniel A Laheru; Hina Arif-Tiwari; Priya Bhosale; Candice W Bolan; Olga R Brook; Abraham F Bezuidenhout; Richard K G Do; Samuel J Galgano; Ajit H Goenka; Alexander R Guimaraes; David M Hough; Naveen Kulkarni; Ott Le; Lyndon Luk; Lorenzo Mannelli; Michael Rosenthal; Guillermo Sangster; Zarine K Shah; Erik V Soloff; Parag P Tolat; Marc Zins; Elliot K Fishman; Eric P Tamm; Atif Zaheer
Journal:  Abdom Radiol (NY)       Date:  2022-10-14

3.  ASO Author Reflections: Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.

Authors:  Kei Kitamura; Minoru Esaki; Miyuki Sone; Shunsuke Sugawara; Nobuyoshi Hiraoka; Satoshi Nara; Daisuke Ban; Takeshi Takamoto; Takahiro Mizui; Kazuaki Shimada
Journal:  Ann Surg Oncol       Date:  2022-06-01       Impact factor: 4.339

4.  Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.

Authors:  Kei Kitamura; Minoru Esaki; Miyuki Sone; Shunsuke Sugawara; Nobuyoshi Hiraoka; Satoshi Nara; Daisuke Ban; Takeshi Takamoto; Takahiro Mizui; Kazuaki Shimada
Journal:  Ann Surg Oncol       Date:  2022-06-12       Impact factor: 4.339

5.  Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.

Authors:  Sanne Lof; Maarten Korrel; Jony van Hilst; Adnan Alseidi; Gianpaolo Balzano; Ugo Boggi; Giovanni Butturini; Riccardo Casadei; Safi Dokmak; Bjørn Edwin; Massimo Falconi; Tobias Keck; Giuseppe Malleo; Matteo de Pastena; Ales Tomazic; Hanneke Wilmink; Alessandro Zerbi; Marc G Besselink; Mohammed Abu Hilal
Journal:  Ann Surg Oncol       Date:  2019-12-17       Impact factor: 5.344

6.  Splenic-vasculature involvement is associated with poor prognosis in resected distal pancreatic cancer.

Authors:  Feng Yin; Mohammed Saad; Jingmei Lin; Christopher R Jackson; Bing Ren; Cynthia Lawson; Dipti M Karamchandani; Belen Quereda Bernabeu; Wei Jiang; Teena Dhir; Richard Zheng; Christopher W Schultz; Dongwei Zhang; Courtney L Thomas; Xuchen Zhang; Jinping Lai; Michael Schild; Xuefeng Zhang; Hao Xie; Xiuli Liu
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-11-24

7.  Prognostic impact of splenic vessel involvement and tumor size in distal pancreatectomy for adenocarcinoma: a retrospective multicentric cohort study.

Authors:  Dominique Gantois; Théophile Guilbaud; Ugo Scemama; Edouard Girard; Olivier Picaud; Marine Lefevre; Myriam Elgani; Zeinab Hamidou; Vincent Moutardier; Paul Balandraud; Mircea Chirica; Louise Barbier; David Fuks; David Jérémie Birnbaum
Journal:  Langenbecks Arch Surg       Date:  2021-08-10       Impact factor: 2.895

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.